Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007887
Filing Date
2025-05-15
Accepted
2025-05-15 16:18:34
Documents
56
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bpth-20250331x10q.htm   iXBRL 10-Q 775335
2 EX-10.3 bpth-20250331xex10d3.htm EX-10.3 29335
3 EX-31 bpth-20250331xex31.htm EX-31 12388
4 EX-32 bpth-20250331xex32.htm EX-32 6185
  Complete submission text file 0001558370-25-007887.txt   3790446

Data Files

Seq Description Document Type Size
5 EX-101.SCH bpth-20250331.xsd EX-101.SCH 33483
6 EX-101.CAL bpth-20250331_cal.xml EX-101.CAL 32215
7 EX-101.DEF bpth-20250331_def.xml EX-101.DEF 128450
8 EX-101.LAB bpth-20250331_lab.xml EX-101.LAB 253196
9 EX-101.PRE bpth-20250331_pre.xml EX-101.PRE 219050
59 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20250331x10q_htm.xml XML 397328
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS, INC. (Filer) CIK: 0001133818 (see all company filings)

EIN.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36333 | Film No.: 25953574
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)